BioSpace News Archive

Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary continuous delivery technology, announced that the US Food and Drug Administration has cleared an investigational new drug application for STAR-OLZ in Chemotherapy Induced Nausea and Vomiting.

Curis, Inc. announced that the U.S. Food and Drug Administration has placed a partial clinical hold on the Company’s TakeAim Leukemia Phase 1/2a study.

Elite Pharmaceuticals, Inc. today announced that together with Elite’s co-development partner, Praxgen Pharmaceuticals LLC received approval from the US Food and Drug Administration (FDA) for doxycycline hyclate 100 mg tablets.

AnPac Bio-Medical Science Co., Ltd. announced that on April 1, 2022, the Company received a Nasdaq Hearing Instructions letter (the “Letter”) from the Nasdaq Stock Market LLC.

Perrigo Company plc today announced that it has launched a private offering (the “Offering”) of $500 million aggregate principal amount of senior notes due 2030,

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of the New Drug Application (NDA) for vutrisiran.

Achilles Therapeutics plc announced that the Company will host a key opinion leader webcast to discuss the importance and unique utility of the TRACERx study in validating the identification of clonal neoantigens as targets for personalized T cell therapies and to highlight selections from the 31 posters and presentations on the TRACERx study presented at the 2022 American Association for Cancer Research Annual Meeting.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data from the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS), presented over the weekend at the American Academy of Neurology (AAN) annual meeting, held in Seattle, Washington.

Amedisys, Inc., a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of Evolution Health, LLC, a provider of home health services.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the acquisition of MD Orthopaedics, including its bracing product lines and the patented Mitchell Ponseti® Ankle-Foot Orthosis system for the treatment of clubfoot.